Prescription Discount Cards 2026: Free vs Paid & Medicare

If your prescriptions cost more than you can pay, someone has probably told you to get a discount card. It is decent advice as far as it goes. But if you have Medicare Part D, there is one sentence on Medicare’s own website that changes the math, and almost nobody hears it before they hand the card to the pharmacist.

Here it is, word for word from Medicare.gov:

“TrumpRx and other types of discount cards aren’t considered creditable coverage. When you use them (instead of your Medicare plan) to buy drugs, it doesn’t count toward your Medicare deductible or out-of-pocket maximum.”

That applies to the free cards and the paid ones equally. This guide compares the options side by side — and is honest about the one comparison that matters most if you are on Medicare.

Esta guía también está disponible en español.

The Comparison, in One Table

Five things get called “a discount card” in ordinary conversation. They are not the same, and only some of them count toward your Medicare spending.

	What it costs you	What it actually is	Counts toward your Part D $2,100 cap?
Free nonprofit card (e.g. NeedyMeds)	$0	A negotiated cash price at the counter	No
TrumpRx.gov (federal website)	$0 — “TrumpRx is free to use”	A federal listing of cash prices and coupon offers	No
Paid discount membership	A yearly fee of “$12 to as high as $100,” sometimes a per-prescription fee	A negotiated cash price, behind a fee	No
State Pharmaceutical Assistance Program (SPAP)	Usually free to apply; varies by state	Supplemental drug coverage run by a state	Yes — 42 CFR 423.100
Extra Help (Medicare’s Low-Income Subsidy)	Free to apply through Social Security	An actual subsidy inside Part D	Yes

The fee figures come from the NeedyMeds discount card FAQ; the “free to use” quote is from TrumpRx.gov’s own FAQ; the counting rule comes from Medicare and from the federal regulation cited in the last column.

Read the last column again. A discount card is a way to pay less today. A program is a way to spend less this year. They are different tools, and the second kind is the one that gets you to $0.

Why Card Spending Does Not Count

This is the part that is buried in the regulation, so here is the plain version.

Medicare’s 2026 drug cost stages work like this: you pay any deductible your plan has (no plan may charge more than $615 in 2026), then 25% coinsurance, until your out-of-pocket spending on covered Part D drugs reaches $2,100. After that you pay $0 for covered drugs for the rest of the calendar year.

The federal rule that decides what gets added to that running total is the definition of “incurred costs” in 42 CFR 423.100. Boiled down, what counts is cost-sharing on covered Part D drugs — money you pay because of your plan’s deductible or copay rules — plus a short list of specific outside payers.

When you buy a prescription with a discount card, none of that happens. The pharmacy rings it up as a cash sale. Your plan is never billed, so there is no cost-sharing, so there is nothing to record. You may well pay less that day. You also stay exactly as far from $2,100 as you were that morning.

Two practical consequences:

• On a cheap generic, the card usually wins. If a drug costs $9 cash and $12 through your plan, the $2,100 cap is not realistically in play for you this year anyway, and $3 is $3.
• On an expensive drug, the card can quietly cost you. Saving $60 on a $400 fill feels good — but paying that fill through your plan would have moved you $400 closer to the point where everything afterward is free.

There is no rule of thumb that covers every case. The point is to ask the question at the counter instead of assuming the card is always the better deal.

The Rule That Changed in 2025

Here is the piece almost no summary mentions, and it works in your favor.

The same regulation used to be strict about outside help: money paid by a third party generally did not count toward your out-of-pocket total. That changed. 42 CFR 423.100 now includes, as incurred costs, amounts “For 2025 and subsequent years, that are reimbursed through insurance, a group health plan, or certain other third party payment arrangements,” excluding only your own basic Part D coverage and the manufacturer discount that Part D applies automatically.

So the direction of travel is: help from an outside source is now more likely to count than it used to be — but a discount card is still not “help from an outside source.” It is just a lower price.

The same section carries one more sentence worth knowing if you get medicine through a drug company’s patient assistance program. Nominal cost-sharing tied to a drug supplied by “a patient assistance program providing assistance outside the Part D benefit” counts as an incurred cost — but only “provided that documentation of such nominal cost-sharing has been submitted to the Part D plan.” In other words, that small amount can count, and it will not count by itself. Somebody has to send the paperwork to your plan.

Free Card vs Paid Membership

Now the narrower comparison people actually search for.

	Free nonprofit card	Paid discount membership
Up-front cost	$0	Annual fee “$12 to as high as $100”
Per-prescription cost	None	Some charge a “processing fee” per prescription
Typical discount	Published range of “0-80%,” varying by drug and pharmacy	Also a negotiated cash price — same mechanism
If your drug is not covered	You lose nothing	You have already paid the fee
Is it insurance?	No	No
Who stands behind it	A 501(c)(3) nonprofit, a state, or a federal site	A for-profit company

Every figure in that left-hand column is from NeedyMeds, the nonprofit behind one of the best-known free cards — and the honest thing about NeedyMeds is that it publishes the unflattering numbers about its own product. It says discount cards “are not a form of insurance,” that they are offered “by state governments, drug companies, non-profit and for-profit businesses,” and that “the discounts offered vary widely from 0-80%.” Its card page advertises “up to 80% off.” Zero is inside the same published range.

Its advice on paid cards is one sentence long: “Carefully evaluate any and all costs involved, such as handling or shipping fees. The fee may add up to more than the discount.”

Three tests before you pay a fee for anything:

1. Is your exact medicine on the list? NeedyMeds: “Contact the program to see what medicine is available before making a payment.”
2. What is the refund policy on the fee? Ask before, not after.
3. What does the pharmacy charge without any card? Many chains “offer some generic prescriptions for $4-$10.” The FTC notes that generics “typically cost 80-85% less” than the brand, “according to estimates from the Food and Drug Administration.”

We are not going to name or link the paid card companies. That is not because they are all dishonest — it is because this site does not send readers to businesses that charge a fee to stand between them and a program. Our full guide to the nonprofit route is how NeedyMeds works.

What the FTC Says About Paid Discount Plans

The Federal Trade Commission’s warning is about medical discount plans in general, not prescription cards specifically, but the mechanics are identical and so are the red flags. From Spot Health Insurance Scams:

“Medical discount plans charge you a monthly fee for discounts on specific medical services or products from a list of participating providers. They’re not a substitute for health insurance. While some medical discount plans provide legitimate discounts, others take people’s money and offer very little in return.”

The FTC’s instructions are to “check out every claim the plan makes” and to “get the details of the discount plan in writing before you sign up.” In a June 2025 consumer alert it added the simplest test of all: “Don’t decide on the spot.” Pressure to sign up immediately is itself the warning sign.

And on the offers that arrive uninvited, the FTC is unambiguous in How To Get Generic Drugs and Low-Cost Prescriptions:

“If you get emails, texts, or messages on social media saying free or low-cost prescription drugs are just a phone call away — or you visit a website that says it can help you get free prescription drugs for a fee — it’s likely a scam.”

Why a Drug Company’s Copay Card Says “Not Valid With Medicare”

If you have ever picked up a manufacturer’s copay card and found small print excluding people on Medicare, that is not the company being difficult. It is federal law.

42 CFR 1003.1000 lets the HHS Office of Inspector General penalize any person who “offers or transfers remuneration… to any individual eligible for benefits under Medicare” when they know or should know it “is likely to influence such individual to order or to receive from a particular provider, practitioner, or supplier, any item or service” Medicare may pay for. And 42 CFR 1003.110 defines “remuneration” to include “the waiver of copayment, coinsurance and deductible amounts (or any part thereof).”

A copay coupon does exactly that. So it is closed to you once you are on Medicare.

Two things are not closed to you:

• The manufacturer’s patient assistance program. That is a different thing from a copay coupon — it supplies the medicine itself rather than paying your Part D copay — and these programs commonly do accept people with Medicare. Ask the drug company directly, or search by drug name through NeedyMeds.
• An independent charity fund. Foundations that help with copays are separate from the manufacturers, and they do serve people on Medicare. Our guide to the HealthWell Foundation explains how those funds work and why the fund you need may be closed when you apply.

What Medicare’s State Program Lookup Actually Shows

A State Pharmaceutical Assistance Program is the discount card’s opposite in every way that matters: it is coverage rather than a price, it coordinates with your Part D plan, and its payments do count toward your out-of-pocket threshold under 42 CFR 423.100.

So we ran Medicare’s own State Pharmaceutical Assistance Program lookup for every state and territory it offers, one at a time, on September 7, 2026, and recorded the eligibility criteria Medicare prints for each program. What we found:

• Five are not in the tool at all: Alaska, Hawaii, Nebraska, Oklahoma and West Virginia.
• Of the 47 that are, 33 list only programs carrying the eligibility line “Patient is living with HIV or AIDS.” If that is not your situation, those listings do nothing for you.
• 14 list at least one program that is not restricted to HIV or AIDS: Delaware, Indiana, Maine, Maryland, Massachusetts, Missouri, New Jersey, New Mexico, New York, Pennsylvania, Rhode Island, Texas, Vermont and Wisconsin.
• Only 9 list a program that Medicare tags with “Age eligibility” and no HIV requirement: Delaware, Indiana, Maine, Massachusetts, New Jersey, New York, Pennsylvania, Rhode Island and Wisconsin.

The honest reading of that is not encouraging, and you should hear it plainly: in most of the country, there is no state drug program waiting for an ordinary older adult. But it takes two minutes to check your own state, and if you are in one of those nine, it is worth far more than any card. Pennsylvania alone lists five separate programs; Wisconsin’s is called SeniorCare; New York’s is EPIC.

One warning if you do get outside coverage. Federal rules put the duty to tell your plan on you: under 42 CFR 423.464, “a Part D enrollee must disclose all these expenditures to a Part D plan,” and 42 CFR 423.32 says enrollees “must provide information regarding reimbursement for Part D costs through other insurance, group health plan or other third-party payment arrangement.” If the plan pays wrong because it did not know, the same rule says it “is authorized to recover such costs directly from the Part D enrollee.” Tell your plan.

What to Do at the Counter

You do not need to work any of this out in advance. You need to ask four questions, and your pharmacist can answer all of them in about a minute.

1. “What is my copay through my plan, and what is the cash price with this card?” Both numbers, out loud, before anything is rung up.
2. “Is there a generic version, and what does that cost?” Your pharmacy already has to tell you this: 42 CFR 423.132 requires a Part D plan to make the pharmacy “inform an enrollee of any differential between the price of that drug and the price of the lowest priced generic version” available there.
3. “If I use the card, does this go through my Part D plan?” If the answer is no — and for a discount card it is no — that fill will not move you toward the $2,100 cap.
4. “Is there a cheaper way to get this?” NeedyMeds’ own advice: “If you have several plans or cards, your local pharmacist will usually tell you the least expensive way to get your medicine.”

Then, separately from the counter, do the one thing that pays more than any card: check whether you qualify for Extra Help. In 2026 it takes a Part D premium and deductible to $0 and caps drugs at $5.10 generic / $12.65 brand, and the income limit is $23,940 for an individual — more than many people assume. NeedyMeds says the same thing in its own checklist: a patient assistance program is “usually… the better option” than a card.

If a Card Is Not the Answer

• Your income is low and you are on Medicare. Start with Extra Help and a Medicare Savings Program. They are different programs with different limits — our guide comparing Medicare Savings Programs and Extra Help explains why being denied one does not decide the other.
• You are not on Medicare at all. Medicaid covers prescriptions for people who qualify, and a community health center charges on a sliding scale based on family size and income. Many have a discounted pharmacy in the building.
• One expensive drug for one condition. A copay foundation such as the HealthWell Foundation may have a fund for it.
• The medicine bill is squeezing everything else. If you are 60 or older, out-of-pocket medical costs can raise your SNAP benefit through the medical expense deduction — a step most people never take.
• You are not sure where to start. Dial 2-1-1. Our 211 guide explains what that call can and cannot do.

How We Checked This

What we opened and read ourselves. We read the federal regulation, not a summary of it: the definition of “incurred costs” in 42 CFR 423.100, the out-of-pocket threshold in 423.104(d)(5), the coordination-of-benefits and disclosure rules in 423.464 and 423.32, the generic-price disclosure duty in 423.132, and the beneficiary-inducement penalty in 42 CFR 1003.1000 and 1003.110. The dollar figures came from Medicare.gov, the card facts from NeedyMeds, the scam warnings from FTC Consumer Advice, and the cash-price site facts from TrumpRx.gov itself. All of it was read on September 7, 2026.

We counted the state programs ourselves rather than repeat a number. Medicare’s State Pharmaceutical Assistance Program lookup does not publish a summary, so we queried it state by state — all 47 it offers — and read the eligibility criteria Medicare prints under each program. The counts in this guide (47 offered, 5 absent, 33 HIV-only, 14 not HIV-restricted, 9 age-gated without an HIV requirement) are our tally of that day’s results, and anyone can reproduce them at the link above. One judgment call, stated openly: Maryland’s “Senior Prescription Drug Assistance Program” is named for older adults but Medicare’s listing does not tag it with “Age eligibility,” so we left it out of the nine. Our rule was to count what the page says, not what a program name implies.

Three things people believe that the rules contradict.

• “A discount card helps me reach my Medicare cap faster.” The exact opposite. Medicare states card purchases don’t “count toward your Medicare deductible or out-of-pocket maximum,” and the regulation explains why: the pharmacy never bills your plan, so no cost-sharing exists to record. On an expensive drug, using the card can leave you further from $0 at year end than paying the copay would have.
• “Nothing anyone else pays for me ever counts.” That was closer to true before 2025 and is not the rule now. 42 CFR 423.100 counts costs “For 2025 and subsequent years, that are reimbursed through insurance, a group health plan, or certain other third party payment arrangements.” Outside help counts; a lower price does not.
• “Every state has a drug program for seniors.” Our own census of Medicare’s tool says otherwise: five states are not in it at all, and in 33 of the 47 that are, every listed program requires an HIV or AIDS diagnosis.

What we could not check, and are not going to pretend we did.

• The HHS Office of Inspector General website is blocked from where we work. Every request to oig.hhs.gov — including its Special Advisory Bulletin on pharmaceutical manufacturer copayment coupons — returned HTTP 403. That bulletin is the document usually cited for the copay-coupon rule. We could not read it, so we did not quote it. What we say about copay coupons rests only on the two regulations we could read in full, 42 CFR 1003.1000 and 1003.110, and we have kept the claim to what those sections actually say.
• We did not use any card at a pharmacy. We cannot tell you what any card saves on any specific drug, and nobody honestly can — the published range starts at zero.
• We did not verify individual state programs. We report what Medicare’s tool listed on one day. Call the program before you rely on it.
• We did not confirm how any particular charity’s payment is treated by any particular plan. The regulation describes categories; your plan applies them to your claim. Ask your plan directly.
• The NeedyMeds savings counter has not moved. It read “Over $340,677,484.00” on July 29, on September 4, and again today. It is presented like a running total. Read it as a static claim.

Discount cards, state programs, pharmacy prices and drug lists all change, and the figures above are the 2026 federal amounts rather than a quote for your medicine at your pharmacy. Everything here was verified on September 7, 2026.

This is general information, not legal or financial advice.